The Benefits Of Estrogen Therapy

One of the most common side effects of the implant is irregular bleeding. The woman can spot or can begin to have longer and heavier periods. In addition, the implant can cause a woman to have breast pain (caused by the high levels of progesterone), headaches, nausea, weight gain, and ovarian cysts. Women who should avoid getting this form of birth control are women who have breast cancer. They should not take this form of birth control because this type of cancer is related to sensitivity of progesterone. Lastly, if a woman has vaginal bleeding that is unexplained, she should not use this form of birth control because the implant can cause the woman to spot, therefore, when she spots, it will be hard to tell if it is from the implant or from some other unexplained

In having the hormone replacement therapy, there are long-term and short-term benefits. In the long term estrogen levels will be higher than average reducing vaginal dryness and urethritis. Preventions of fractures, heart disease, colon cancer, or dementia and most commonly reduce breast and uterine cancer.

MHT is recommended for use short-term relief, at the lowest dose. There are two types: Estrogen plus Progestin and Estrogen alone. Estrogen plus progestin increases the risk of development and dying from breast cancer. When these hormones are in use, there is a danger of having an abnormal mammogram increases the first year of use and then keeps increasing within the first five years of use. The use of Estrogen alone increases the risk of breast cancer by about 30 percent. A study by the women's health initiative showed there was a decrease of risk of breast cancer after about seven years of use. There is no increased risk of breast cancer if the women used estrogen alone for less than ten years, but there was an increase in the likelihood of breast cancer after 20 years of use (Ww5.komen.org,

With menopause estrogen defiency occurs which is associated with increased severity and incidence of OA in women. Estrogen therapy reduces the risk of OA compared to those who are not taking it.(21)

There has been conflicting research and advice about the safety of hormones with the increase in the aging female population within the last twenty years (National Institute on Aging). Hormone therapy has demonstrated to be the most effective FDA approved medication in the relief of menopausal symptoms, but these benefits must be weighed against serious adverse effects that hormones can cause. Although many women differ in their response to hormone products, MHT has been universally linked to an increased risk of heart disease, heart attack, blood clots, and strokes. Concerns about the findings discovered in the clinical and observation trials performed on MHT, have left some doctors and women hesitant in utilizing MHT to combat menopausal

Ovariectomized mice were used to avoid the potential confound of various circulating sex hormones especially estrogen. Moreover, we find out lack of estrogen causes more extensive EAE and different doses of estrogen could protect against EAE. We demonstrated intermediate dose of estrogen (5 fold lower than pregnancy level) could reduce the incidence and severity of clinical disease similar to pregnancy level of estrogen but also lower side effects than high dose estrogen therapy. Further, we discovered administration of low dose estrogen has a beneficial efficiency in treatment of EAE condition, although it will be necessary to perform supplementary investigations in the future

Estrogen treatment: Estrogen-related drugs are sometimes used in hormonal therapy of men with prostate cancer. This treatment may cause a slight increase in breast cancer risk. However, this risk is small compared with the benefits of this treatment in slowing the growth of prostate cancer. Men taking high doses of

Biologically, sex is determined by chromosomes, (XX = female and XY = male). That is primarily how one is determined male or female. However, Daniela Crocetti (2013), argues that chromosomes are not the only determining factor, that instead some people can be born with an imbalance in their hormone and testosterone system, this imbalance attributes to qualities that are more commonly seen in the opposite sex. This trait is most commonly seen through transexuals. Hormonal therapy is an option for those who experience these certain types of imbalances, it focuses on the “gendered presentation of the body and behavioral components…”. As a result, the therapy tends to make one feel “like how they're supposed to feel”. However, what if one prefers

As a result, the body can't tell the difference between bioidentical hormones and the ones produced in your body. Experts report that a heavy decrease in the negative side effects associated with other hormone replacement treatments. However, some can still occur, and they include:

Estrogen plays many functions in our body. One of its primary functions is associated with skeletal growth and bone homeostasis, including the inhibition of bone reabsorption. In women affected by estrogen deficiency, the decrease levels trigger an increased production of cell mediators such as cytokines (interleukin-1, interleukin-6, and TNF) leading to the stimulation and proliferation of osteoclast precursors. Decreased level of estrogen also contributes to osteoclast differentiation via RANK pathways. Therefore, even in the presence of osteoblastic activity as a compensatory mechanism, to produce new bone formation, this activity cannot keep up with the higher rate of bone loss, leading to early osteoporotic

Excess exposure to exogenous estrogen is a major cause of EC, which can be through unopposed estrogen therapy, use of tamoxifen, and phytoestrogens.20,21,22 Systemic estrogen therapy such as oral tablets, vaginal rings, and patches have been found to increase the risk of endometrial hyperplasia or EC.21 Estrogen replacement after menopause have also being found to cause an increased risk when not adequately countered with progesterone replacement.21 Prospective cohort and case control studies have demonstrated an association between these sources and EC, with the dose and duration of use implicated in the increased incidence (RR range: 1.1 to 15 ). In a prospective study between 1996 to 2001, about 716,738 postmenopausal women were recruited to examine their use of replacement therapy and EC risk, there was increased risk of EC in women on estrogen only therapy(1.45 [1.02-2.06]; p=0.04), and reduced risk in those with cyclic combined therapy (relative risk 0.71 [95% CI 0.56-0.90]; p=0.005), when compared to women who have never used hormonal replacement therapy.20

Estrogen and its metabolites evidently have critical involvement in the pathogenesis of tumorigenesis/carcinogenesis. Early menarche, late menopause or estrogen replacement therapy (ERT) increases the risk of developing breast cancer due to the increased exposure to estrogen and dependence of tissue origin i.e., breast, cervix and endometrium. Three important molecules involved in estrogen regulation such as estrogen receptor (ER) which relays the estrogenic signal, estrogen sulfotransferase, inactivates the estrogen through sulfation, Sulfatase, activates estrogen by desulfation and Formylglycine generating enzyme which regulates STS activity. These three molecules were found to have altered expression or function in tumor/cancer cells compared to normal

Estrogen (17 β-estradiol) takes part in a multitude of physiological processes either as initiator or modulator. The effects of estrogen in the body are highly documented and its roles have been intensively studied. The effect of estrogen has been associated with the presence of two classical nuclear estrogen receptors namely Estrogen Receptor-α (ER-α) (Green et al. 1986; Greene et al. 1986) and Estrogen Receptor-β (ER-β) (Kuiper et al. 1996). Both of these are considered as factors that bring about ligand-activated transcription. These factors are located in the cytosol where they bind estrogen molecules and then this Estrogen-ER complex is translocated to the nucleus and there it interacts with nuclear response elements which are present

: Having testosterone and estrogen blocked is not a very good thing for a woman, especially when dealing with her menstrual cycle. If her testosterone is blocked that could cause many different abnormal symptoms along the way. When she is dealing with her menstrual cycle it can cause extra hair on the facial area and acne as well. According to (Friedman 2016) the woman can become overweight and have insulin resistance. She can start developing menopause like symptoms and hypopituitarism. These are symptoms if her testosterone was blocked. When she is dealing with estrogen which is important to the body. First have to realize just why women would need estrogen. Estrogen is produced by mainly in the ovaries, it is produced by adrenal glands.

Side effects of estrogen strength incorporate adamant weight gain, tension, premenstrual indications of breast sensitivity, skin inflammation, irritability, exhaustion and brain fogginess.